Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77,784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency.
Kim O, Butler M, Sergi Z, Robey RW, Zhang M, Chari R, Pang Y, Yu G, Zhang W, Song H, Davis D, Hawley RG, Wen X, Wang H, Quezado M, Tran B, Merchant M, Ranjan A, Furnari FB, Khan J, Gilbert MR, Ryan Miller C, Gottesman MM, Pommier Y, Wu J. Kim O, et al. Among authors: wu j. Neurooncol Adv. 2023 Aug 21;5(1):vdad102. doi: 10.1093/noajnl/vdad102. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37706203 Free PMC article.
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.
King AL, Shuboni-Mulligan DD, Vera E, Crandon S, Acquaye AA, Boris L, Burton E, Choi A, Christ A, Grajkowska E, Jammula V, Leeper HE, Lollo N, Penas-Prado M, Reyes J, Theeler B, Wall K, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: wu j. Neurooncol Pract. 2022 Jun 22;9(6):526-535. doi: 10.1093/nop/npac049. eCollection 2022 Dec. Neurooncol Pract. 2022. PMID: 36388423 Free PMC article.
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering.
Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, Polskin L, Wu J, Gilbert MR, Armstrong TS, Celiku O. Bergsneider BH, et al. Among authors: wu j. Neurooncol Adv. 2022 Dec 26;5(1):vdac188. doi: 10.1093/noajnl/vdac188. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36820236 Free PMC article.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye-Mallory AA, Adegbesan KA, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill ML, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: wu j. J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0. Epub 2023 Mar 8. J Neurooncol. 2023. PMID: 36884201 Free PMC article. Clinical Trial.
Long-term survivors of glioblastoma: Tumor molecular, clinical, and imaging findings.
Briceno N, Vera E, Komlodi-Pasztor E, Abdullaev Z, Choi A, Grajkowska E, Kunst T, Levine J, Lindsley M, Fernandez K, Reyes J, Boris L, Burton E, Panzer M, Polskin L, Penas-Prado M, Pillai T, Theeler BJ, Wu J, Wall K, Papanicolau-Sengos A, Quezado M, Smirniotopoulos J, Aldape K, Armstrong TS, Gilbert MR. Briceno N, et al. Among authors: wu j. Neurooncol Adv. 2024 Feb 8;6(1):vdae019. doi: 10.1093/noajnl/vdae019. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38420614 Free PMC article.
A patient-derived cell model for malignant transformation in IDH-mutant glioma.
Kim O, Sergi Z, Yu G, Yamamoto K, Quezado M, Abdullaev Z, Crooks DR, Kishimoto S, Li Q, Lu P, Blackman B, Andresson T, Wu X, Tran B, Wei JS, Zhang W, Zhang M, Song H, Khan J, Krishna MC, Brender JR, Wu J. Kim O, et al. Among authors: wu x, wu j. Acta Neuropathol Commun. 2024 Sep 10;12(1):148. doi: 10.1186/s40478-024-01860-6. Acta Neuropathol Commun. 2024. PMID: 39256867 Free PMC article.
Association of Employment Status With Symptom Burden and Health-Related Quality of Life in People Living With Primary CNS Tumors.
Leeper HE, Vera E, Christ A, Acquaye A, Briceno N, Choi A, Grajkowska E, Jammula V, Levine J, Lindsley M, Reyes J, Roche KN, Rogers JL, Timmer M, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai V, Polskin L, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. Leeper HE, et al. Among authors: wu j. Neurology. 2023 Apr 18;100(16):e1723-e1736. doi: 10.1212/WNL.0000000000207082. Epub 2023 Feb 8. Neurology. 2023. PMID: 36754634 Free PMC article.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye AA, Adegbesan K, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill M, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: wu j. Res Sq [Preprint]. 2023 Jan 31:rs.3.rs-2522094. doi: 10.21203/rs.3.rs-2522094/v1. Res Sq. 2023. Update in: J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0 PMID: 36789426 Free PMC article. Updated. Preprint.
77,784 results
You have reached the last available page of results. Please see the User Guide for more information.